References
- Steward PA. Home Page Review of Pharmaceutical Controlled Release Methods and Devices. 1998. Accessed from the website: https.//www.initium.demon.co.uk/rel_nf.htm.
- Definition of Controlled Release. A system that: Delivers an agent at a controlled rate for an extended time. Might localize drug action by spatial...users.rowan.edu/.../Controlled%20Release/.../Introduction%20and%20background%20(1).pdf - États-Unis - Pages similaires.
- Walther M. Key considerations for the rational design of oral controlled release products. 2006. www.initium.demon.co.uk/rel_nf.htm
- Swarbrick J, Boylan JC. Encyclopedia of pharmaceutical technology. 2nd ed. Vol. 3. New York: Marcel Dekker; 2002:2067–2080.
- Ghebre-Sellassie I, Knoch A. Pelletization techniques. In: Encyclopedia of pharmaceutical technology. 2nd ed. Vol. 3. New York: Marcel Dekker; 2002:2067–2080.
- Bouffard J, Dumont H, Bertrand F, Legros R. Optimization and scale-up of a fluid bed tangential spray rotogranulation process. Int Journ Pharm 2007;335:54–62.
- Vetchy D, Rabiskova M. Some variables influencing rotoagglomeration in the multiprocessor MP-1. Int J Pharm 2002;242:353–356.
- Vilhemsen T, Kristensen J, Schaefer T. Melt pelletization with polyethylene glycol in a rotary processor. Int J Pharm 2004;275:141–153.
- Vilhemsen T, Schaefer T. Agglomerate formation and growth mechanism during melt agglomeration in a rotary processor. Int J Pharm 2005;304:152–164.
- Kristensen J, Wallaet Hansen W. Wet granulation in rotary processor and fluid bed: Comparison of granule and tablet properties. AAPS Pharm Sci Tech 2006;7(1): art 22.
- Gauthier P. Formulation de microspheres de principes actifs en rotogranulation – Etude de divers excipients. PhD Thesis, Univ. Auvergne, Clermont-Ferrand, FR; 1995.
- Aiache JM, Gauthier P. Applications of rotary fluidized bed processing. Part I: Manufacturing spheres. Pharmaceut Technol Eur 2001;13(9):22–34.
- Gauthier P, Aiache JM. Manufacture and dissolution studies of lipid spheres. Part I. Pharmaceut Technol Eur 2003;15(10):55–66.
- Gauthier P, Aiache JM. Manufacture and dissolution studies of lipid spheres. Part II. Pharmaceut Technol Eur 2003;15(11):34–36.
- Amidon G, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceut Res 1995;12:413–420.
- Rinaki E, Valsami G, Macheras P. Quantitative biopharmaceutics classification system: The central role of dose/solubility ratio. Pharmaceut Res 2003;20:1917–1925.
- Löbenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification systems. New scientific approaches to international regulatory standards. Eur J Pharmaceut Biopharmaceut 2000;50:3–12.
- Dressmann J, Butler J, Hempenstall J, Reppas C. The BCS: Where do we go from here? Pharmaceut Technol 2001;13(7):68–76.
- Theophylline monohydrate. 2008. European Pharmacopoeia 6.0. pp 3286–3287.
- Rowe RC, Sheskey PJ, Quinn ME. Povidone. Handbook of pharmaceutical excipients. 6th ed. APhA 2009:581–585.
- Rowe RC, Sheskey PJ, Quinn ME. Castor oil, hydrogenated. Handbook of pharmaceutical excipients. 6th ed. APhA 2009:128–129.
- Gauthier P, Aiache JM. Application of rotary fluidized bed processing, Part II: Fizzy spheres. Pharmaceut Technol Eur 2001;13(10):32–37.
- Dissolution. US Pharmacopeia National Formulary. USP 33, NF 28, 2010:76–83.
- Gauthier P, Paillard B, Aiache JM. Single step sustained release mini-sphere preparation; 1997. French patent FR 2742659.